Steris (STE) Issues FY 2019 Earnings Guidance

Steris (NYSE:STE) updated its FY 2019 earnings guidance on Monday. The company provided earnings per share guidance of $4.74-4.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.76. The company issued revenue guidance of $2.751-2.751 billion, compared to the consensus revenue estimate of $2.75 billion.

STE stock traded up $1.27 during midday trading on Monday, reaching $119.86. The stock had a trading volume of 772,423 shares, compared to its average volume of 413,651. The firm has a market capitalization of $10.03 billion, a price-to-earnings ratio of 28.88 and a beta of 1.04. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.63 and a quick ratio of 2.01. Steris has a 52-week low of $83.44 and a 52-week high of $121.67.

STE has been the subject of a number of research analyst reports. Sidoti raised their target price on Steris from $155.00 to $157.00 and gave the stock a buy rating in a research note on Thursday, December 6th. Zacks Investment Research restated a buy rating and issued a $132.00 target price on shares of Steris in a research note on Friday, November 16th. Finally, KeyCorp raised their target price on Steris from $120.00 to $132.00 and gave the stock an overweight rating in a research note on Tuesday, November 13th. Five equities research analysts have rated the stock with a buy rating, The company currently has a consensus rating of Buy and a consensus price target of $134.20.

In other Steris news, VP John Adam Zangerle sold 3,000 shares of the stock in a transaction dated Friday, January 25th. The stock was sold at an average price of $115.00, for a total transaction of $345,000.00. Following the sale, the vice president now directly owns 33,796 shares of the company’s stock, valued at approximately $3,886,540. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.38% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Steris (STE) Issues FY 2019 Earnings Guidance” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2019/02/11/steris-ste-issues-fy-2019-earnings-guidance.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Insider Trading

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply